Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Cj Corp, a prominent South Korean conglomerate, is renowned for its diversified portfolio that spans several significant sectors, including food, biotechnology, logistics, entertainment, and media. Founded as Cheil Jedang in 1953, the company commenced operations in the food industry, producing sugar and flour. Since then, Cj Corp has expanded its reach and influence, establishing a strong market presence through its subsidiaries and brands, such as CJ CheilJedang, known for its food and bio businesses, and CJ Logistics, a leader in logistics and supply chain management. In the entertainment sphere, Cj Corp has made substantial contributions through CJ ENM, producing films, dramas, and music, thereby shaping cultural narratives and trends. This positions Cj Corp as an integral player in both national and global entertainment markets. Additionally, its innovation in the bio-technology sector underscores a commitment to sustainable development and health solutions. In summary, Cj Corp is a multifaceted entity that plays a vital role in various industries, driving economic growth and technological advancement in South Korea and beyond.
€163,300.00
+€3,300.00 (+2.06%)
Live · 05:25 PM
Operating margin is thin at 5.61%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 3.1%, steady but not accelerating. Free cash flow declined 26% despite revenue growth, conversion is weakening.
Free cash flow declined 26% versus the prior year, cash generation momentum has weakened. Net debt of ₩15.26T represents 9.4x FCF, leverage limits flexibility.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
₩45.87T
▲ +3.1% YoY
Net Income (TTM)
₩184.41B
▼ -5.7% YoY
Op. Margin
5.36%
▼ -0.2pp YoY
ROIC
3.51%
Cash Flow & Balance Sheet
FCF (TTM)
₩1.49T
▼ -25.8% YoY
Op. Cash Flow (TTM)
₩3.52T
▲ +20.8% YoY
Net Debt
₩15.26T
Cash & Equiv.
₩3.25T
3Y CAGR: +3.2%
3Y CAGR: +41.3%
Continue Research
Cj (001040.XKRX) trades below a two-stage DCF intrinsic value of about KRW 618,894.05 per share, so at KRW 163,300.00 the stock looks undervalued (279.0% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Cj scores 47/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about KRW 618,894.05 per share for 001040.XKRX, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around KRW 464,170.54. At today's KRW 163,300.00, that puts the stock about 279.0% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Cj scores 47 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 5.4% operating margin and a 3.5% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. 001040.XKRX currently trades below its estimated intrinsic value and scores 47/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.